Conor M. Douglas

4700 Keele Street
Toronto, ON M3J1P3, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

How social pharmaceutical innovations are addressing problems of availability, accessibility and affordability of drugs for rare diseases.

How social pharmaceutical innovations are addressing problems of availability, accessibility and affordability of drugs for rare diseases.

Journal: Orphanet journal of rare diseases

Published: April 10, 2025

Lessons learned from the Canadian Fabry Disease Initiative for future risk-sharing and managed access agreements for pharmaceutical and advanced therapies in Canada.

Lessons learned from the Canadian Fabry Disease Initiative for future risk-sharing and managed access agreements for pharmaceutical and advanced therapies in Canada.

Journal: Health policy (Amsterdam, Netherlands)

Published: June 14, 2023

International Experiences and Made-in-Canada "Social Pharmaceutical Innovations" as Responses to Challenges Facing Drugs for Rare Diseases.

International Experiences and Made-in-Canada "Social Pharmaceutical Innovations" as Responses to Challenges Facing Drugs for Rare Diseases.

Journal: HealthcarePapers

Published: January 24, 2023

Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases.

Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases.

Journal: Orphanet journal of rare diseases

Published: February 28, 2022

Parental perspectives on retention and secondary use of neonatal dried bloodspots: a Dutch mixed methods study.

Parental perspectives on retention and secondary use of neonatal dried bloodspots: a Dutch mixed methods study.

Journal: BMC pediatrics

Published: March 26, 2019

Evaluating Canadians' Values for Drug Coverage Decision Making.

Evaluating Canadians' Values for Drug Coverage Decision Making.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: March 14, 2018

Editors introduction: biobanks as sites of bio-objectification.

Editors introduction: biobanks as sites of bio-objectification.

Journal: Life sciences, society and policy

Published: January 31, 2018

Mothers' Views on Longer Storage of Neonatal Dried Blood Spots for Specific Secondary Uses.

Mothers' Views on Longer Storage of Neonatal Dried Blood Spots for Specific Secondary Uses.

Journal: Public health genomics

Published: March 12, 2015

Governing the research-care divide in clinical biobanking: Dutch perspectives.

Governing the research-care divide in clinical biobanking: Dutch perspectives.

Journal: Life sciences, society and policy

Published: February 01, 2015

Why orphan drug coverage reimbursement decision-making needs patient and public involvement.

Why orphan drug coverage reimbursement decision-making needs patient and public involvement.

Journal: Health policy (Amsterdam, Netherlands)

Published: August 02, 2014

Rethinking biobanking and translational medicine in the Netherlands: how the research process stands to matter for patient care.

Rethinking biobanking and translational medicine in the Netherlands: how the research process stands to matter for patient care.

Journal: European journal of human genetics : EJHG

Published: February 17, 2014

Challenges for the European governance of synthetic biology for human health.

Challenges for the European governance of synthetic biology for human health.

Journal: Life sciences, society and policy

Published: August 13, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026